Answers are grounded in this paper and cite their sources.
Metabolomics is a powerful technology which shows great potential in biomarker discovery. A total of three urinary differential metabolites were identified, and more important, these biomarkers may be sensitive to early diagnosis of ALD disease.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: